A Core Treatment for Autism

ATOO1 is in the final stages of development for a core symptom of autism (repetitive behaviors). Numerous clinical studies have indicated that AT001 has the potential to be a safe and effective treatment for patients suffering with this condition. 

Read more about AT001 here.

What is Autism?

Autism (referred to in DSM IV as autistic disorder) is a Pervasive Developmental Disorder (PDD). Related developmental disorders defined in the DSM-IV are Asperger’s Disorder and Pervasive Developmental Disorder – Not Otherwise Specified (PPD-NOS). Together these three are sometimes called Autistic Spectrum Disorder (ASD), or simply autism.

Read more about autism here. 

What’s New?

For more information on recent news, updates, and press releases, as well as other current information relevant to Autism Therapeutics, please visit our Media Center. You can also find relevant publications and research there.

Get up to date news and press releases here.